Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity
Journal of Cancer Treatment and Research
Volume 5, Issue 3, May 2017, Pages: 39-42
Received: Sep. 17, 2016; Accepted: Mar. 17, 2017; Published: Mar. 27, 2017
Views 2103      Downloads 100
Author
Omar H. Al-Obaidi, Chemistry Department, Education College for Girls, Al-Anbar University, Ramadi, Iraq
Article Tools
Follow on us
Abstract
"The new complexes of Cr(III), Mn (II), Fe(III) and Cu(II) complexes with the chalcone ligand were studied on the growth of Rhabdomyo sarcomas (RD) cell Line in human by using in vitro system and compared with anticancer drug cis-platin (cis-pt) as appositive control. The cancer cells were treated with different concentration and cis-pt after 72 hr. exposure time. The cytotoxic activity was tested by inhibition rate as parameter. The results showed significant differences (p<0.05) for each three treatments when the inhibition rates were increased. The synthesized compounds were tested for antimicrobial activity by cup plate diffusion method. The results indicate the enhanced activity of metal complexes over the parent ligands. The synthesized complexes have been screened for in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus, and new prepared complexes were compared with anticancer drug cis-platin."
Keywords
Chalcone, Complexes, Antimicrobial Activity, Cytotoxicity Cisplatin
To cite this article
Omar H. Al-Obaidi, Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity, Journal of Cancer Treatment and Research. Vol. 5, No. 3, 2017, pp. 39-42. doi: 10.11648/j.jctr.20170503.12
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
A. W. Star, and T. J. Marby, Phytochemistry, 10, 2812 (1971).
[2]
D. N. Dhar, Wiley, 213 (1981).
[3]
K. Satyanarayana and M. N. A. Rao., Indian Drugs, 30.313 (1993).
[4]
T. Torigoo, M. Arisawa, S. IIoch, M. Fujiu and H. B. Mayuyama, Biochem. Biophys. Res. Commun., 112, 833.
[5]
M. L. Go, X. Wu and X. L. Liu, Current. Medicinal. Chemistry, 12, 483 (2005).
[6]
Young Hoon Kim, Jeongsoo Kim, Haeil Park, Hyun Pyo Kim, Biol. Pharm. Bull, 30 (80), pp 1450-1455, (2007).
[7]
W. Shen Jeu, L. Cheng Tsung, T. Lo Ti, W. Jing Ru, K. Hrogn Huey, W. Jih Pyang and L.
[8]
Chun Nan, Eur. J. Med. Chem., 40, 103 (2005).
[9]
N. Liming, W. J. Kimberly, M. Weingarten and S. A. Janes, PCT Int. Appl., 411 (2003).
[10]
E. Francesco, G. Salvatore, M. Luigi and C. Massimo, Phytochem, 68, 939 (2007).
[11]
S. Ducki, R. Forrest, J. A. Hadfield, A. Kendall, N. J. Lawrence, A. T. Mc Gown and D.
[12]
Rennson, Bioorg. Med. Chem. Lett., 8, 1051 (1998).
[13]
E. Bombardelli, and P. Valenti, PCT Int. Appl., 18 (1998).
[14]
M. Chen, T. G. Theander, S. B. Christensen, L. Hrlid, Zhai and A. Kharazmi, Antimicrob. Agents. Chemother, 38, 1470 (1994).
[15]
J. C. Onyilagha, B. Malhotra, M. Elder and G. H. N. Towers, Can. J. Plant. Pathol, 19, 133 (1997).
[16]
H. X. Xu, M. Wan, H. Dong, P. But and L. Y. Foo, Biol. Pharm. Bull., 23, 1072 (2000).
[17]
Omar H. Al-Obaidi,” Synthesis, Spectral Characterization, Theoretical Evaluation Of New Cr (III), Co (II), Fe(III) And Cu(II) Complexes”, App. Sci. Report., 12 (1), 2015: 41-45. And Saad M. Mahdi, Russel I. Aliway,” Preparation and identification of a new azo-chalcone ligand (VACAN) and its complexes with some divalent transition metal ions’, Iraqi National Journal of Chemistry 2015; 15 (2).
[18]
Freshney, R. I., “Cultured of Animal Cells: A manual for Basic Techniques “, Inc. Publication, New York, pp 64-69, 2000. And El-Sayed YS, Gaber M. “Studies on chalcone derivatives: complex formation, thermal behavior, stability constant and antioxidant activity Spectrochim Acta A Mol Biomol Spectrosc. (2015); 137: 423-31.
[19]
Gao, X., Xu, X., Janakiraman, N., Gautam, S. C., “Disparate in vivo Antileukemic Effect of Reserveratol a Natural Polyphenolic Compound Found in Grapes”, Nutr.., 132, pp 2076-2081, 2002.
[20]
Vandpitte J., et al. (1991), "Basic laboratory procedures in clinical bacteriology "WHO, Genevap. pp 78-110).
[21]
Birt, F. D, Hendrich, S, Wang, W., “Dietary Agents in Cancer Prevention Flavonoids and Isoflavonoids Pharmacology and Therapeutics”, USA, pp 157-177, 2001.
[22]
Tsuda, S., Matsusaka, N., Madaram H., Ueno, S., Susa, N., Ishida, K., Kawamura, N., Sekihashi, K., Sasak, Y., “the Comet Assay in Eight Mouse Organs Results with 2 Azo Compounds”, Mutat. Res., 465, pp 1139-1151, 2000.
[23]
Kenyon, G., Puja, G., Harbach, R., Wayne, G., Ping Dou, Q., “Organic Copper Complexes as new Class of Proteasome Inhibitors and Apoptosis Inducers in Human Cancer Cells,” Bioc. Pharm. 67, pp 1139-1151, 2004.
[24]
Saadiyah, A. D., Jinan H., and Iman H., J. of Al-Nahrain Univ., 15 (2), pp 23-28, 2012.
[25]
Stordal B., Davey, M.,” Vander Standing cisplatin Resistance Using Cellular Models”, IUBMB Life, 59, pp 696-9, 2007.
[26]
Y. Anjaneyalu, R. P. Rao, Synth. React. Inorg.-Org. chem. 16, 1986, pp. 257.
[27]
L. Mishra, V. H. Singh, Indian J. Chem. 32A, 1993, pp. 446.
[28]
S. Sumathi, P. Tharmaraj, C. D. Sheela, R. Ebenezer, “Synthesis, spectral, bioactivity, and NLO properties of chalcone metal complexes”, Journal of Coordination Chemistry 64 (10): 1707-1717. 2011.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186